Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHENYLMERCURIC BORATE - REFERENCE SPECTRUM (N/A)

PHENYLMERCURIC BORATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
PHENYLPROPANOLAMINE HYDROCHLORIDE CRS - * DRUG PRECURSOR (50

PHENYLPROPANOLAMINE HYDROCHLORIDE CRS - * DRUG PRECURSOR (50

154-41-6

DISCOVER
PHENYTOIN CRS (120 MG)

PHENYTOIN CRS (120 MG)

57-41-0

DISCOVER
PHENYTOIN SODIUM CRS (250 MG)

PHENYTOIN SODIUM CRS (250 MG)

630-93-3

DISCOVER
PHTHALYLSULFATHIAZOLE CRS (100 MG)

PHTHALYLSULFATHIAZOLE CRS (100 MG)

85-73-4

DISCOVER
PHYSOSTIGMINE SALICYLATE CRS (100 MG)

PHYSOSTIGMINE SALICYLATE CRS (100 MG)

57-64-7

DISCOVER
PHYTOMENADIONE CRS (150 MG)

PHYTOMENADIONE CRS (150 MG)

84-80-0

DISCOVER
TRANS-EPOXYPHYTOMENADIONE CRS(5 MG)

TRANS-EPOXYPHYTOMENADIONE CRS(5 MG)

NA

DISCOVER
Primidone

Primidone

125-33-7

DISCOVER
Propranolol D7

Propranolol D7

344298-99-3

DISCOVER
PICOTAMIDE MONOHYDRATE CRS (125 MG)

PICOTAMIDE MONOHYDRATE CRS (125 MG)

80530-63-8

DISCOVER
PICOTAMIDE IMPURITY A CRS (25MG)

PICOTAMIDE IMPURITY A CRS (25MG)

2206-43-1

DISCOVER